Asian Pacific Journal of Tropical Biomedicine

: 2018  |  Volume : 8  |  Issue : 12  |  Page : 571--579

Gac fruit extracts ameliorate proliferation and modulate angiogenic markers of human retinal pigment epithelial cells under high glucose conditions

Ali Abdulqader1, Faisal Ali2, Amin Ismail3, Norhaizan Mohd Esa4,  
1 Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
2 Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia; Biochemistry & Molecular Biology Department, University Hospital, Faculty of Medicine and Health Sciences, Sana'a University, Yemen
3 Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences; Research Center of Excellent, Non-Communicable Diseases (NNCD) Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400, Serdang, Selangor, Malaysia
4 Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences; Research Center of Excellent, Non-Communicable Diseases (NNCD) Faculty of Medicine and Health Sciences; Laboratory of Molecular Biomedicine, Institute of Bioscience, Universiti Putra Malaysia, 43400, Serdang, Malaysia

Correspondence Address:
Prof. Amin Ismail
Research Center of Excellent, NNCD, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor


Objective: To investigate the impact of the extracts of Gac fruit parts (peel, pulp, seed, and aril) on the cell viability and angiogenesis markers of human retinal pigment epithelial (ARPE- 19) cells under high glucose conditions. Methods: The effect of the extracts of Gac fruit peel, pulp, seed and aril on the ARPE-19 cells was determined using MTT viability assay, Trypan blue dye and morphological changes were observed using light microscopy. Enzyme-linked immunosorbent-based assay was performed to evaluate the effect of Gac fruit parts on the reactive oxygen species (ROS), vascular endothelial growth factor (VEGF) and pigmented epithelium-derived factor (PEDF) secretions. Results: High glucose (HG) at 30 mmol/L increased ARPE-19 cell viability and ROS and VEGF secretions. While, the exposure of ARPE- 19 cells in high glucose condition to Gac fruit extracts led to inhibition of cell viability, induced morphological changes, decreased ROS and VEGF secretions, and increased PEDF level. Gac pulp, seed, and aril at 1 000 μg/mL showed significant inhibition activities [(7.5 ± 5.1)%, (2.7 ± 0.5)%, (3.2 ± 1.1)%, respectively] against HG-induced ARPE-19 cell viability. The findings also demonstrated that Gac aril at 250 μg/mL significantly decreased ROS and VEGF levels [(40.6 ± 3.3) pg/mL, (107.4 ± 48.3) pg/mL, respectively] compared to ROS [(71.7 ± 2.9) pg/ mL] and VEGF [(606.9 ± 81.1) pg/mL] in HG untreated cells. Moreover, 250 μg/mL of Gac peel dramatically increased PEDF level [(18.2 ± 0.3) ng/mL] compared to that in HG untreated cells [(0.48 ± 0.39) ng/mL]. Conclusions: This study indicates that the extracts of Gac peel, pulp, seed and aril reduced cell viability, minimized ROS generations and showed angiogenic activities. Therefore, our findings open new insights into the potentiality of Gac fruit against HG-related diabetic retinopathy disease.

How to cite this article:
Abdulqader A, Ali F, Ismail A, Esa NM. Gac fruit extracts ameliorate proliferation and modulate angiogenic markers of human retinal pigment epithelial cells under high glucose conditions.Asian Pac J Trop Biomed 2018;8:571-579

How to cite this URL:
Abdulqader A, Ali F, Ismail A, Esa NM. Gac fruit extracts ameliorate proliferation and modulate angiogenic markers of human retinal pigment epithelial cells under high glucose conditions. Asian Pac J Trop Biomed [serial online] 2018 [cited 2019 Jun 20 ];8:571-579
Available from:

Full Text

 1. Introduction

Diabetic retinopathy (DR) is a microvascular destructive disease and is one of the common consequences of diabetes[1]. Hyperglycaemia is a primary factor in the initiation and progression of vascular complications related to eye diseases in diabetes such as DR[2],[3]. However, the mechanisms by which hyperglycaemia leads towards vascular dysfunction still require further investigation.

Notwithstanding, it has been established that chronic exposure to hyperglycaemia by the microvascular in the retina is associated with several pathological changes. Of these changes, the over-production of reactive oxygen species (ROS) and the loss of homeostasis in the angiogenesis process have been identified as the major contributing factors[4],[5],[6]. Chronic exposure of retinal cells to hyperglycaemia gives chances to increase ROS by activation of different enzymatic pathways[7],[8]. ROS is a toxic-free radical with impaired electron, such as superoxide radical, hydroxyl radical and hydrogen peroxide radical. Over-production of ROS may lead to increased oxidative stress and this could be the main pathogenesis of DR[9]. Increased ROS production could be either from large excesses of free radicals and/or a failure of the antioxidant systems such as vitamin E, A and C, carotenoids, polyphenols, glutathione or other radical degrading mechanisms to destroy the number of free radicals being formed[9].

Clinically, DR is categorised into two main classes, namely; nonproliferative DR (NPDR) and proliferative DR (PDR)[10]. PDR is the final stage of DR characterised by the uncontrolled growth of abnormal blood vessels that leak and bleed into the retina, inevitably leading to blindness[11]. The process of growing new blood vessels from pre-existing vessels is known as angiogenesis which is a very accurate process, tightly controlled by inhibitor and stimulator angiogenic markers[12],[13]. The vascular endothelial growth factor (VEGF) is one of the most studied markers that acts as a stimulator for the angiogenesis process and is found to be elevated in patients with PDR[14]. Whereas, the pigmented epithelium-derived factor (PEDF) has been shown to be an inhibiting factor in the angiogenesis process, and found at a lower level among patients with PDR[15],[16]. Retinal pigment epithelial (RPE) cells play an important role in the visual function and DR development[17]. The major functions of RPE cells include nutrients, minerals, water, glucose and ions transport. Moreover, RPE plays a role in the generation of angiogenic markers, such as VEGF, PEDF, insulin growth factor (IGF), and fibroblast growth factor (FGF)[18],[19].

Natural sources (i.e. plants, vegetables, fruits) are rich in phytochemicals and bioactive constitutes that are widely reported to have health-promoting activities for human benefits[20]. Of these natural sources, carotenoids-rich fruits play an important role in the management of diabetes-related diseases[21],[22]. Gac (Momordica cochinchinensis Spreng) is a tropical fruit, indigenous to Southeast Asian countries and reported to be a rich source of phytochemicals, especially carotenoids[23]. Carotenoids have been linked with the prevention of eyes disorders, such as age-related macular degradation and cataracts[24]. Furthermore, the consumption of carotenoids-rich foods has been associated with a decreased risk of DR development and visual acuity improvement through ROS neutralising, neuroprotective and anti-inflammatory functions[24],[25],[26],[27]. Gac fruit extracts were acknowledged to have pharmacological activities via suppressing migration and invasion of breast cancer cells[28], reversing tert-butyl peroxide-induced cell damage[29], and reducing wet tumor weight in vivo[30]. However, limited information about the effect of extracts of Gac peel, pulp, seed and aril on the treatment of hyperglycaemia-related DR disease has been found. Therefore, this study aimed at investigating the impact of Gac fruit parts on the proliferation and angiogenesis activity of human retinal pigment epithelial (ARPE-19) cells in high glucose (HG) conditions.

 2. Materials and methods

2.1 Chemicals and reagents

In undertaking this study, the following chemicals and reagents were used; Dulbecco’s Modified Eagle’s Medium (DMEM), fetal bovine serum, phosphate buffer saline (PBS), penicillin and streptomycin, trypsin-EDTA (1×), and Trypan blue dye, dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO USA), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma-Aldrich, Billerica, MA USA), human ROS, modulator 1 ELISA kit (E1924h, EIAab, Wuhan, China), human VEGF and human EDF ELISA kits (CUSABIO, Wuhan, China). Other reagent analytical grade chemicals were also used along with pure distilled water for all experimental steps.

2.2 Collection of Gac fruit

Gac (Momordica cochinchinensis Spreng) fruit Malaysian cultivar was supplied from the International Tropical Fruits Network, Selangor, Malaysia. Eleven ripe fruits were randomly collected during the harvesting season in October of 2017. Collectively, all fruits collected weighed 8 kg, and the average individual weight was about (755 ± 185) g. The fruits were then kept separately in sealed plastic bags and stored in -80 °C for a few weeks until they were ready to use.

2.3 Fruit extract preparation

The Gac fruit was removed from storage and exposed to room temperature in order to completely thaw, followed by washing with tap water to remove any debris. The fruit was next separated into four parts; peel, pulp, seed, and aril. It was then cut into small slices and pieces, followed by each fruit part being lyophilised using a freeze dryer at -45 °C for 3 d (BT2K, VirTis, Warminster, USA). The freeze-dried parts were then ground, mixed, extracted with 70% ethanol at the ratio of 1:20 (w/v), and vigorously shaken using an orbital shaker (SHO-2D, Daihan Scientific, Seoul, Korea) at 180 rpm, for 2 h and filtered. Next, the obtained extract was evaporated using a rotary evaporator (R-210, Buchi, Flawil, Switzerland). The extract following evaporation (sticky and dark liquid extract) was then dried using a freeze dryer, and finally, the resulting dried extract was stored at a temperature of -20 °C for further use.

2.4 Cell culture

Human RPE (ARPE-19) cells were purchased from the American Type Culture Collection (Rockville, MD, USA). In order to grow the cells, ARPE-19 was grown in DMEM complete media supplied in 1% penicillin/streptomycin and 10% fetal bovine serum (v/v). A humidified incubator at a temperature of 37 °c in 5% CO2 condition was used to incubate the flasks containing the cells. The passage number used during all experiments was between P6 and P12.

2.5 Cell viability under different glucose conditions

ARPE-19 cells were seeded in DMEM with low glucose (LG) (5.5 mmol/L) at a density of 5 000 cells/well using 96-well plate. On the second day, the media were replaced with 100 μL of media containing different glucose concentrations (5.5, 30, 50, 70, 100 mmol/L). After 48 h, the media were removed and 20 μL of MTT (1 mg/mL) was added to each well and incubated for 4 h[31]. Then, the MTT was removed carefully and 100 μL of DMSO was added. The absorbance was read at 570 nm using a microplate reader (VersaMax, Sunnyvale, USA), and 630 nm was used as a reference wavelength. The results were expressed as percentage for three triplicates using the following formula:

Cell viability percentage (%) = OD570-630 of each HG (30, 50, 70, 100 mmol/L) /OD570-630 of LG (5.5 mmol/L) × 100 Where OD = Optical density.

2.6 Cytotoxicity evaluation

ARPE-19 cells were plated in 96-well plate at 5 000 cell/well density with 100 μL of DMEM with LG (5.5 mmol/L) media and were allowed to attach overnight. ARPE-19 cells were divided into groups including: ARPE-19 with LG (5.5 mmol/L) and HG (30 mmol/L), ARPE-19 with different concentrations (31.2-1 000 μg/mL) of extracts obtained from freeze dried peel, pulp, seed and aril in HG (30 mmol/L). After 48 hours of incubation, all media were removed, 20 μL of MTT (1 mg/mL) was added to each well and incubated for 4 h[31]. MTT was then removed and 100 μL of DMSO was added. The absorbance was read at 570 nm using a microplate reader and 630 nm was used as a reference wavelength. The results were expressed as percentage for three measurements using the following formula: Cell viability percentage (%) = OD570-630 of HG groups (treated and non-treated) /OD570-630 of LG group χ 100 Where OD = Optical density.

2.7. Cell morphology examination

Using 6-well plates, the ARPE-19 cells were seeded at a density of 300 000 cells/well in LG media, allowing to attach overnight. Next, the medium of each well was removed, and the cells were washed twice with PBS (1×). After that, the ARPE-19 cells were exposed to 2 mL of HG (30 mmol/L) media containing different concentrations (62.5-1 000 μg/mL) of the Gac fruit extracts (peel, pulp, seed and aril). In this assay, the concentration of Gac extracts started from 62.5 μg/mL because small concentrations might not be effective to induce morphology changes. The untreated cells with HG and LG media were also considered. Following 48 hours of incubation, a light-inverted microscope was used to observe the normal morphological changes.

2.8. Trypan blue dye assay

For further determining the effects of Gac fruit extracts on ARPE- 19 cell viability, 6-well plates were used, and 300 000 ARPE-19 cells were seeded with LG (5.5 mmol/L). After 24 h, the media were removed, then ARPE-19 cells were incubated with 2 mL of LG (5.5 mmol/L) and HG (30 mmol/L), and with different concentrations (31.2-1 000 μg/mL) of extracts obtained from freeze dried peel, pulp, seed and aril dissolved in HG (30 mmol/L) respectively. After 48 hours of incubation, the medium of each group was removed and the cells were detached using Trypsin-EDTA. After entirely detaching, the cells’ suspensions were centrifuged at 1 200 rpm, 4 °C for 5 min. Next, the supernatant was discarded, and the pellet was suspended with 1 mL of PBS. Finally, 10 μL of the resulting cell suspension was blended with 10 μL of 0.4 % Trypan blue solution, and then the ARPE-19 cells were microscopically counted using a haemocytometer chamber under a light-inverted microscope[32].

2.9. Measurement of ROS level

Doses of Gac extracts used in the previous evaluations were to assess the IC50 and toxic doses, resulting in the usage of three (low, medium and high) non-toxic doses of Gac parts extracts in further experiments. To determine the level of ROS, 200 000 cells of ARPE- 19 were seeded in 6-well culture plate with LG (5.5 mmol/L). On the second day, all media were discarded and ARPE-19 cells were washed twice with 1×PBS. Next, ARPE-19 cells were incubated with different groups of media including: ARPE-19 with LG (5.5 mmol/L) and HG (30 mmol/L), and ARPE-19 in HG (30 mmol/L) with different concentrations (50, 100 and 250 μg/mL) of extracts from freeze dried Gac peel, pulp, seed and aril. In accordance to the protocol defined by the manufacturer (E1924h, EIAab, Wuhan, China), the medium of each group was collected in test tubes and centrifuged at 1 000 ×g, at 4 °C for 10 min. Next, 100 μL of the sample’s supernatants and standards were added to the 96-wells plate coated with a specific antibody for ROS and incubated for 2 h at 37 °C Next, the liquid of each well was discarded, and 100 μL of the detection reagent A was added. Following 1 hour of incubation at 37 °C the liquid was removed, and the wells were washed 3 times with washing buffer, and 100 μL of detection reagent B was added. After 1 hour of incubation at 37 °C, the liquid was removed from the wells and washed five times with washing buffer. Then, 90 μL of substrate solution was added to each well, protected from light and incubated at 37 C for 15-30 min. Finally, 50 μL of stop solution was added to each well, and the absorbance was read within 10 min at 450 nm using a microplate reader. The concentration of ROS was then calculated based on the standard curve of ROS.

2.10. Measurement of VEGF and PEDF levels

To determine the VEGF and PEDF levels, ARPE-19 at 200 000 cells/ well density was seeded with LG (5.5 mmol/L) using a 6-well plate. After 24 hours of incubation, the media were discarded and the cells were washed twice with 1× PBS. Next, ARPE-19 cells were incubated with different groups of media including: ARPE-19 with LG (5.5 mmol/L) and HG (30 mmol/L); ARPE-19 with HG (30 mmol/L) containing different concentrations (50, 100 and 250 μg/mL) of extracts obtained from freeze dried peel, pulp, seed and aril and incubated for 48 h. VEGF and PEDF levels were measured in each group according to the manufacturer’s protocol (CSB-E11718h VEGF, CSB-E088181h PEDF, Wuhan, China). The media were collected and centrifuged at 1 000 × g, at 4 °C for 10 min. Next, 100 μL of the samples and standards were added to the 96-wells plate that was pre-coated with specific antibodies for VEGF and PEDF. After 2 hours of incubation at 37 °C, the liquid was removed, and 100 μΕ of Biotin-antibody (1×) was added to each well. Following 1 hour of incubation at 37 °C , the liquid was carefully discarded, and the wells were washed 3 times with washing buffer (1×). Next, 100 μL of HRP-avidin (1×) was added to each well and incubated for 1 h at 37 °C. Then, the liquid was then discarded, and the wells were washed 5 times with washing buffer. After that, 90 μL of TMB substrate was then added to each well, protected from light and incubated at 37 °C. Finally, 50 μL of stop solution was added, and the absorbance was read at 450 nm using a microplate reader within 5 min. The concentrations were calculated based on the standard curve of VEGF and PEDF of three measurements.

2.11. Statistical analysis

The data was presented as mean ± standard deviation (SD). The analysis of the significance and differences among the means was undertaken through One-way ANOVA and Tukey’s post hoc multiple comparison test. Differences in the means were considered statistically significant at P < 0.05. Notably, all experimental data values were statistically subjected using the GraphPad PRISM program version 6.01.

 3. Results

3.1. Cell viability under different glucose concentrations

As illustrated in [Figure 1], LG group at 5.5 mmol/L had the lowest ARPE-19 cell viability. Among the groups with different concentrations higher than 5.5 mmol/L, there were no statistically significant differences. However, HG group at 30 mmol/L had the highest ARPE-19 cell viability. For this reason, HG at 30 mmol/L was used for further experiments with LG at 5.5 mmol/L as a control group.{Figure 1}

3.2. Effect of extracts from Gac fruit parts on ARPE-19 cell viability

Gac fruit extracts (peel, pulp, seed and aril) at different concentrations were evaluated for cell toxicity against ARPE-19 cell line in HG condition at 30 mmol/L. ARPE-19 cell viability significantly increased in HG group (100 ± 9)% compared to LG group (64.3 ± 7.5)% [Figure 2]. The effect of Gac extracts on cell viability was dependent on the dose. Pulp, seed and aril at 1 000 μg/mL had the most cytotoxic effect towards ARPE-19 cell viability [(7.5 ± 5.1)%, (2.7 ± 0.5)% and (3.2 ± 1.1)% respectively]. In contrast, peel at 1 000 μg/mL appeared to have a moderate cytotoxic effect on ARPE-19 cell viability [(41.2 ± 7.1)%]. In addition, Gac seed extract had the highest IC50 equivalent to 190 μg/mL.{Figure 2}

3.3. Effect of extracts from Gac fruit parts on ARPE-19 morphological changes

It was noticed through inverted microscope that there were remarkable variations in the cell morphology of treated cells as shown in [Figure 3]. Elevated concentrations of the fruit peel, pulp, seed and aril extracts led to increasing morphology changes and decreased cell viability as clearly shown in 1 000 μg/mL of ARPE-19 treated groups compared to other doses. These alterations included: cell detachments, floating, cell spherical and rounding shape, and cell shrinkage. Furthermore, the marked morphology chagnes were observed in the ARPE-19 cells treated with seed and pulp extracts, indicating their dramatic impact on the ARPE-19 cell viability and morphology. According to [Figure 3], the Gac extracts appeared to arrest and slow the proliferation and duplications of ARPE-19 cells. However, there were no similar changes observed on the untreated cells.{Figure 3}

3.4. Trypan blue dye evaluation

To further confirm the effects of Gac parts extract on ARPE-19 cell viability, Trypan blue dye was applied. The results were consistent with the morphological examinations, where the number of ARPE- 19 cells decreased when the extract dose increased. As seen in [Figure 4], there was a significant increase in the number of ARPE-19 cells in HG [(483 000.0 ± 4.2) cells], higher than that of LG [(345 000.0 ± 4.3) cells] groups. Gac seed at 1 000 μg/mL dramatically decreased ARPE-19 cells number [(48 000.0 ± 1.2) cells], followed by (95 000.0 ± 1.2) cells of Gac pulp at the same dose. In contrast, Gac aril and peel at the highest dose showed the lowest reducing ability [(213 000.0 ± 3.5) cells, (168 000.0 ± 2.5) cells, respectively]. Collectively, seed and pulp parts at moderate and high doses showed more significant differences (P < 0.05) than Gac peel and aril in reducing ARPE-19 cell viability.{Figure 4}

3.5. Effects of extracts from Gac fruit parts on ROS level

[Figure 5] shows level of ROS in different groups of ARPE-19 cells. Comparatively, the level of ROS in HG [(71.7 ± 2.9) pg/mL] was significantly higher than in LG [(58.0 ± 4.3) pg/mL] group. Furthermore, the Gac fruit parts were able to reduce the ROS level generated by the ARPE-19 cells in HG conditions, but the results varied concerning the extracts’ ability to minimise the ROS level. Gac aril at 250 μg/mL significantly reduced ROS level [(40.6 ± 3.3) pg/mL], followed by pulp [(49.9 ± 2.7) pg/mL], seed [(51.2 ± 5.7) pg/mL], and lastly peel [(55.3 ± 5.6) pg/mL].{Figure 5}

3.6. Effects of extracts from Gac fruit parts on VEGF Level

[Figure 6] demonstrates the level of VEGF produced by ARPE- 19 cells treated with different concentrations of Gac extracts in HG conditions. As illustrated, the level of VEGF produced by the untreated ARPE-19 cells in HG group [(606.9 ± 81.1) pg/mL] was significantly higher (P < 0.05) compared to the VEGF level produced in LG group [(307.9 ± 30.3) pg/mL]. Among the treated groups, Gac aril at 250 μg/mL reduced VEGF level most significantly. Gac pulp at 250 μg/mL and aril at 100 μg/mL also showed significant anti- VEGF activity compared to the HG control.{Figure 6}

3.7. Effects of extracts from Gac fruit parts on PEDF level

As seen in [Figure 7], there were no significant differences between the level of PEDF among LG and HG cells, even though the level of PEDF in the HG group [(0.48 ± 0.39) ng/mL] was less than that found in the LG group [(1.85 ± 0.21) ng/mL]. Gac peel at 250 μg/mL showed the highest level of PEDF [(18.2 ± 0.3) ng/mL] followed by seed [(13.9 ± 4.0) ng/mL] at 250 μg/mL. In contrast, Gac peel showed significant increase of PEDF level at all doses, while Gac pulp at both 100 and 250 μg/mL doses as well as Gac seed and aril at only 250 μg/mL demonstrated the markedly increase.{Figure 7}

 4. Discussion

Gac fruit has been traditionally used in folk and ancestral medicine and treatments for several conditions. Newly, several biological effects and health benefits of Gac fruit have been revealed, such as antioxidant, anti-proliferative, anti-cancer, and antibacterial activities. In the present study, the effects of extracts from Gac fruit parts (peel, pulp, seed, and aril) on ARPE-19 cell viability, cellular morphology and ROS, VEGF, PEDF generations in high glucose conditions were investigated for the first time. The results revealed that Gac fruit parts reduced ARPE-19 cell viability, induced morphological changes, decreased ROS, VEGF productions, and increased PEDF levels.

Chronic exposure to hyperglycaemia by the retina is one of the most threatening issues among diabetes patients which leads to PDR and lastly blindness. PDR is characterized by retinal neovascularization due to hypoxia that produces abnormal blood vessels which bleed and leak into the retina. RPE cells play a crucial role in the progression of such condition. A recently published report showed that HG induced abnormal activation of RPE cells which might be associated with PDR development[33].

The results of this study revealed that HG increased ARPE-19 cell viability when compared to LG, which was consistent with a previous study that reported a 2-fold increase in cell viability in HG than LG condition[34]. Amongst the fruit parts, Gac seed at the highest concentration 1 000 μg/mL had the highest anti-proliferative activity tested by MTT and Trypan blue dye. This was in line with the results of some studies published earlier which demonstrated that Gac seed exhibited considerable suppression activity against the proliferation of breast cancer cells ZR-75-30[28], normal HaCat and melanoma D24[35], and lung cancer cell A549[36]. In this study, Gac seed and pulp induced noticeable morphological changes, such as cells condensation, floating, detachments, spherical and rounding shapes, and these characteristics might be due to the cytotoxic effect of high doses. Recently, studies reported that Gac seed water extract also induced morphological changes and cytotoxic effect against normal HaCat, melanoma D24 and C1 cell lines[35]. However, the molecular mechanisms, such as apoptotic and necrotic pathways underlying Gac extracts-induced ARPE-19 morphological changes, need to be further studied. Gac aril in this study also inhibited ARPE-19 cell viability which was consistent to another study which revealed that water extract taken from Gac aril significantly reduced MCF-7 and melanoma with a rate of 60% and 70%, respectively[37]. In addition to the seed and aril parts, this study has also showed that Gac peel and pulp reduced ARPE-19 cell viability, but the biological and anti-proliferative potentiality of Gac pulp and peel has not been studied well.

One of the essential initiators of DR development is ROS, which has been noticed to be elevated by chronic hyperglycaemia[38],[39]. High concentrations of glucose were found to stimulate ROS production in RPE in vitro[33],[40]. This finding was in agreement with the result of this study which revealed that HG (30 mmol/L) led to an increase in ROS level produced by ARPE-19 compared to a lower level in LG (5.5 mmol/L). This increment can be naturally avoided by the antioxidant defence system. However, in some conditions such as chronic hyperglycaemia, the balance between ROS and the antioxidant system is disrupted[41]. Thus, it is necessary to support and recover the balance and decrease the level of ROS in the management of PDR. Furthermore, the results of this study showed the ability of extracts from Gac fruit parts to reduce ROS production. This proved the role of phytochemicals and natural sources as antioxidants and their potential ability in the management of DR[42],[43]. Amongst all of the Gac fruit parts, Gac aril exhibited the highest anti-ROS ability which could be due to the rich carotenoids, phenolics and other bioactive compounds found in this part as revealed by previous studies[24],[44]. Gac seed and peel were also found to possess anti-oxidant activities which might be due to rich trypsin inhibitors compounds, saponins, and phenolics content[35],[45].

Retinal neovascularisation as mentioned earlier is the last stage of DR which is characterized by abnormal proliferation and this process is tightly controlled by inhibitors and stimulators of angiogenic factors[46]. Therefore, one of the main strategies to treat PDR is to modulate angiogenesis process by either suppressing angiogenic stimulators, such as VEGF and/or stimulating angiogenic inhibitors, such as PEDF. Current treatment patterns of this process include anti-VEGF drugs injection in addition to laser photocoagulation and surgery[47],[48]. These strategies are extremely expensive and accompanied with undesired results, such as retinal detachments, retinal damage, and vitreous haemorrhage[49],[50]. In this study, HG-induced secretions of VEGF were about 2-fold higher than that in LG group which was consistent with the results of previous studies. It was previously shown that VEGF secretion was highly responsive to the change in glucose concentration, which increased when the glucose dose increased[51]. It was also reported that the VEGF level produced by the ARPE-19 cells increased under HG conditions[52],[53]. HG-stimulated VEGF secretion in ARPE-19 cells as illustrated in this study was reversed when treated with Gac parts extracts. Amongst all of the Gac fruit parts, the aril extract dramatically decreased VEGF secretions, which might be attributed to the rich content of phytochemicals, especially carotenoids. The role of carotenoids in the modulation of angiogenesis markers has been well established[54]. A previous study confirmed the anti-angiogenic activity of lycopene via decreased VEGF production, inhibited tube formation, and migration in human umbilical vein endothelial cells[55].

During this study, the PEDF level was evaluated by using the extracts of Gac fruit parts. The results revealed that the PEDF level of HG group reduced compared to that of LG group, whereas Gac fruit parts boosted the production of PEDF by the ARPE- 19 cells. In PDR, the increase in the level of PEDF is essential in order to balance the high concentration of VEGF that is stimulated by HG thus modulating the angiogenesis process. Although one study showed that the PEDF level was enhanced when treated with xanthatin as a medicinal component from Xanthium[56], limited information has been found regarding the role of phytochemicals in PEDF secretions.

To the best of our knowledge, this study is the first to investigate the effects of Gac fruit extracts on HG-induced PDR biomarkers in vitro. The data revealed anti-proliferative, anti-ROS, angiogenesis biomarkers regulating activities of Gac fruit extracts. Therefore, the current findings suggest that Gac fruit could potentially be utilized as a therapeutic agent in the treatment of HG-related eye disease. However, additional studies are highly needed to explore the active compounds and their mechanisms of actions underlying potential of Gac parts extracts.

Conflict of interest statement

The authors have no conflicts of interest to declare related to this study.


The authors would like to acknowledge Dr Mohd Esa Hassim from the International Tropical Fruits Networks (TFNet), Malaysia for supplying the studied fruits.


This project was supported by Research Grant Number: UPM, GP-IPS/2017/7956600.


1Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: Global prevalence, major risk factors, screening practices and public health challenges: A review. Clin Exp Ophthalmol 2016; 44(4): 260-277.
2King GL, Kunisaki M, Nishio Y, Inoguchi T, Shiba T, Xia P. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes 1996; 45: S105-S108.
3Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, et al. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes 2006; 55(9): 2401-2411.
4Hammes HP. Diabetic retinopathy: Hyperglycaemia, oxidative stress and beyond. Diabetologia 2018; 1: 1-10.
5Guzman DC, Olguín HJ, García EH, Peraza AV, de la Cruz DZ, Soto MP. Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress. Redox Rep 2017; 22(1): 10-16.
6Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005; 438(7070): 960.
7Behl T, Kaur I, Kotwani A. Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol 2016; 61(2): 187-196.
8Al-Shabrawey M, Smith S. Prediction of diabetic retinopathy: Role of oxidative stress and relevance of apoptotic biomarkers. EPMA J 2010; 1(1): 56-72.
9Calderon GD, Juarez OH, Hernandez GE, Punzo SM, De la Cruz ZD. Oxidative stress and diabetic retinopathy: Development and treatment. Eye 2017; 31(8): 1122.
10Wilkinson CP, Ferris Π FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110(9): 1677-1682.
11Barot M, Gokulgandhi MR, Patel S, Mitra AK. Microvascular complications and diabetic retinopathy: Recent advances and future implications. Future Med Chem 2013; 5(3): 301-314.
12Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997; 22(7): 251-256.
13Capitão M, Soares R. Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem 2016; 117(11): 2443-2453.
14Mohan N, Monickaraj F, Balasubramanyam M, Rema M, Mohan V. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. J Diabetes Complicat 2012; 26(5): 435-441.
15Ren JG, Jie C, Talbot C. How PEDF prevents angiogenesis: A hypothesized pathway. Med Hypotheses 2005; 64(1): 74-78.
16Huber M, Wachtlin J. Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Ophthalmologica 2012; 228(3): 188-193.
17Mateos MV, Tenconi PE, Giusto NM, Salvador GA. Inflammation and oxidative stress in retinal diseases: The role of intracellular signaling in the retinal pigment epithelium. Int J Ophthalmol Clin Res 2015; 8: 1-7.
18Simó R, Villarroel M, Corraliza L, Hernández C, Garcia-Ramírez M. The retinal pigment epithelium: Something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol 2010; 2010: 190724.
19Ponnalagu M, Subramani M, Jayadev C, Shetty R, Das D. Retinal pigment epithelium-secretome: A diabetic retinopathy perspective. Cytokine 2017; 95: 126-135.
20Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: A chemical constituents based approach. J Ethnopharmacol 2013; 150(1): 51-70.
21Saini RK, Nile SH, Park SW. Carotenoids from fruits and vegetables: Chemistry, analysis, occurrence, bioavailability and biological activities. Food Res Int 2015; 76: 735-750.
22Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007; 55(3): 207-216.
23Chuyen HV, Nguyen MH, Roach PD, Golding JB, Parks SE. Gac fruit (Momordica cochinchinensis Spreng.): A rich source of bioactive compounds and its potential health benefits. Int J Food Sci Tech 2015; 50(3): 567-577.
24Abdel-Aal ES, Akhtar H, Zaheer K, Ali R. Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients 2013; 5(4): 1169-1185.
25González-Herrero ME, Ruiz M, Román FJ, Sánchez JM, Domingo JC. Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: Prospective controlled study of macular function by fundus microperimetry. Clin Ophthalmol 2018; 12: 1011.
26Dow C, Mancini F, Rajaobelina K, Boutron-Ruault MC, Balkau B, Bonnet F, et al. Diet and risk of diabetic retinopathy: A systematic review. Eur J Epidemiol 2018; 1: 1-6.
27Neelam K, Goenadi CJ, Lun K, Yip CC, Au Eong KG. Putative protective role of lutein and zeaxanthin in diabetic retinopathy. Br J Ophthalmol 2017; 101(5): 551-558.
28Zheng L, Zhang YM, Zhan YZ, Liu CX. Momordica cochinchinensis seed extracts suppress migration and invasion of human breast cancer ZR-75- 30 cells via down-regulating MMP-2 and MMP-9. Asian Pac J Cancer Prev 2014; 15(3): 1105-1110.
29Tsoi AY, Ng TB, Fong WP. Antioxidative effect of a chymotrypsin inhibitor from Momordica cochinchinensis (Cucurbitaceae) seeds in a primary rat hepatocyte culture. J Pept Sci 2005; 11(10): 665-668.
30Tien PG, Kayama F, Konishi F, Tamemoto H, Kasono K, Hung NT, et al. Inhibition of tumor growth and angiogenesis by water extract of Gac fruit (Momordica cochinchinensis Spreng). Int J Oncol 2005; 26(4): 881-889.
31Petchsak P, Sripanidkulchai B. Momordica cochinchinensis aril extract induced apoptosis in human MCF-7 breast cancer cells. Asian Pac J Cancer Prev 2015; 16(13): 5507-5513.
32Ashwaq AA, Al-Qubaisi M, Rasedee A, Abdul A, Taufiq-Yap Y, Yeap S. Inducing G2/M cell cycle arrest and apoptosis through generation reactive oxygen species (ROS)-mediated mitochondria pathway in HT-29 cells by Dentatin (DEN) and Dentatin incorporated in hydroxypropyl-β- cyclodextrin (DEN-HPβCD). Int J Mol Sci 2016; 17(10): 1653.
33Fu D, Tian X. Effect of astaxanthin on retinal pigment epithelial cells in high glucose: An in-vitro study. Biomed Res 2017; 28(15): 6839-6843.
34Heimsath Jr EG, Unda R, Vidro E, Muniz A, Villazana-Espinoza ET, Tsin A. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res 2006; 31(12): 1073-1080.
35Le A, Huynh T, Parks S, Nguyen M, Roach P. Bioactive composition, antioxidant activity, and anticancer potential of freeze-dried extracts from defatted Gac (Momordica cochinchinensis Spreng) seeds. Medicines 2018; 5(3): 104.
36Shen Y, Meng L, Sun H, Zhu Y, Liu H. Cochinchina momordica seed suppresses proliferation and metastasis in human lung cancer cells by regulating multiple molecular targets. Am J Chin Med 2015; 43(01): 149-166.
37Wimalasiri D, Piva T, Huynh T. Diversity in nutrition and bioactivity of Momordica cochinchinensis. Int J Adv Sci Eng Inform Tech 2016; 6(3): 378-380.
38Ranneh Y, Ali F, Akim AM, Hamid HA, Khazaai H, Fadel A. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: A review. J Korean Soc Appl Biol Chem 2017; 60(3): 327-338.
39Kayama Y, Raaz U, Jagger A, Adam M, Schellinger IN, Sakamoto M, et al. Diabetic cardiovascular disease induced by oxidative stress. Int J Mol Sci 2015; 16(10): 25234-25263.
40Kim DI, Park MJ, Choi JH, Lim SK, Choi HJ, Park SH. Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis. Int J Biochem Cell Biol 2015; 59: 41-51.
41Ceriello A, Testa R, Genovese S. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutr Metab Cardiovasc Dis 2016; 26(4): 285-292.
42Kowluru RA, Zhong Q, Santos JM, Thandampallayam M, Putt D,Gierhart DL. Beneficial effects of the nutritional supplements on the development of diabetic retinopathy. Nutr Metab 2014; 11(1): 8.
43Head KA. Natural therapies for ocular disorders, part one: Diseases of the retina. Altern Med Rev 1999; 4(5): 342-359.
44Ishida BK, Turner C, Chapman MH, McKeon TA. Fatty acid and carotenoid composition of gac (Momordica cochinchinensis Spreng) fruit. J Agric Food Chem 2004; 52(2): 274-279.
45Chuyen HV, Roach PD, Golding JB, Parks SE, Nguyen MH. Optimisation of extraction conditions for recovering carotenoids and antioxidant capacity from Gac peel using response surface methodology. Int J Food Sci Tech 2017; 52(4): 972-980.
46Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010; 9735: 124-136.
47Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight 2017; 2(14): 93751.
48Abu El-Asrar AM. Changing paradigms in the treatment of diabetic retinopathy. Saudi J Ophthalmol 2011; 25(2): 97-98.
49Simó R, Hernandez C. Intravitreous anti-VEGF for diabetic retinopathy: Hopes and fears for a new therapeutic strategy. Diabetologia 2008; 51(9): 1574.
50Austeng D, Morken TS, Bolme S, Follestad T, Halsteinli V. Nurse-administered intravitreal injections of anti-VEGF: Study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction. BMC Ophthalmol 2016; 16(1): 169.
51Caprnda M, Kubatka P, Saxena S, Valaskova J, Stefanickova J, Kobyliak N, et al. The impact of hyperglycemia on VEGF secretion in retinal endothelial cells. Folia Med 2017; 59(2):183-189.
52Grigsby J, Betts B, Vidro-Kotchan E, Culbert R, Tsin A. A possible role of acrolein in diabetic retinopathy: Involvement of a VEGF/TGFβ signaling pathway of the retinal pigment epithelium in hyperglycemia. Curr Eye Res 2012; 37(11): 1045-1053.
53Haque R, Iuvone PM, He L, Hur EH, Chung Choi KS, Park D, et al. Prorenin receptor (PRR)-mediated NADPH oxidase (Nox) signaling regulates VEGF synthesis under hyperglycemic condition in ARPE-19 cells. J Recept Signal Transduct 2017; 37(6): 560-568.
54Niranjana R, Gayathri R, Mol SN, Sugawara T, Hirata T, Miyashita K, et al. Carotenoids modulate the hallmarks of cancer cells. J Funct Foods 2015; 18: 968-985.
55Chen ML, Lin YH, Yang CM, Hu ML. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Mol Nutr Food Res 2012; 56(6): 889-899.
56Shen M, Zhou XZ, Ye L, Yuan Q, Shi C, Zhu PW, et al. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2 mediated STAT3/ PI3K/Akt signaling pathway. Int J Mol Med 2018; 42(2): 769-778.